Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
WINLEVI works differently from any other topical acne treatment
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
Subscribe To Our Newsletter & Stay Updated
